Skip to main content
Clinical Trials/IRCT20190306042945N4
IRCT20190306042945N4
Recruiting
Phase 2

The effect of local vibration on restless legs syndrome

Iran University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Restless leg syndrome.
Sponsor
Iran University of Medical Sciences
Enrollment
36
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 60 years
  • Having symptoms for at least 15 days during the 30 days leading up to the start of the intervention
  • Satisfaction with the completion of the project
  • Having 4 criterias
  • Patients with at least moderate symptoms
  • Stop taking any medication for the treatment of restless leg syndrome at least two weeks before

Exclusion Criteria

  • Pregnancy or breastfeeding
  • Reluctance to treat local vibration
  • The presence of a pacemaker or ICD
  • Existence of active malignancy
  • Existence of fracture, open wound, abscess, cellulitis or infection at the place of vibration
  • CKD (GFR\<60\)
  • Iron deficiency anemia (ferritin less than 20\)
  • Vitamin deficiency (Vit D level \< 30\)
  • Deep vein thrombosis (DVT)
  • Evidence of radicular pain, radiculopathy or neuropathy (clinical or paraclinical evidence)

Outcomes

Primary Outcomes

Not specified

Similar Trials